Metabiotics in Colorectal Cancer: Crosstalk Between Gut Microbiota and Host Pathology

Gulati, M; Singh, SK; Kumar, R; Dua, K; Panda, S; Blaxland, J; Chandwani, L

Metabiotics in Colorectal Cancer: Crosstalk Between Gut Microbiota and Host Pathology

Gulati, M Singh, SK Kumar, R Dua, K Panda, S Blaxland, J Chandwani, L

Permalink

Publisher:: Springer
Publication Type:: Chapter
Citation:: Probiotic Research in Therapeutics, 2021, pp. 95-112
Issue Date:: 2021

Closed Access

	Filename	Description	Size
	20066466_9823401600005671.pdf	Published version	522.54 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Gulati, M
dc.contributor.author	Singh, SK
dc.contributor.author	Kumar, R
dc.contributor.author	Dua, K
dc.contributor.author	Panda, S
dc.contributor.author	Blaxland, J
dc.contributor.author	Chandwani, L
dc.date.accessioned	2023-01-06T23:04:18Z
dc.date.available	2023-01-06T23:04:18Z
dc.date.issued	2021
dc.identifier.citation	Probiotic Research in Therapeutics, 2021, pp. 95-112
dc.identifier.isbn	9789811582134
dc.identifier.uri	http://hdl.handle.net/10453/164764
dc.description.abstract	After an extensive research and successful commercialization of probiotics in the past three decades, some scepticism regarding their safety and reproducibility of therapeutic advantage paved the way for “metabiotics”. The name metabiotics is a portmanteau created from the terms metabolites and probiotics. Also known as parabiotics and postbiotics, metabiotics are components of probiotic microorganisms and/or their metabolites with a determined chemical structure, which have been reported to be effective in the prevention and treatment of colorectal cancer (CRC). The main components of metabiotics are short-chain fatty acids (SCFAs), peptides, peptidoglycan-derived muropeptides, enzymes, polysaccharides, vitamins, teichoic acids, proteins and plasmalogens. Metabiotics help in the maintenance of GIT homeostasis and lead to proliferation of the healthy bacteria, which in turn reduces the levels of enzymes that are responsible for conversion of pro-carcinogens to carcinogens. Some components of metabiotics, specifically, SCFAs, have the ability to recognize cancer cells and de-repress the epigenetically silenced genes in them. The chemoprotective enzymes, secretory glycoproteins, certain exopolysaccharides and SCFAs all possess anti-mutagenic properties and exert a prophylactic effect against colorectal cancer. Apart from this, these components regulate the immune function and downregulate the inflammatory mediators, the most prominent causative factor in the development of CRC. Metabiotics have also demonstrated the anti-proliferative effects and have been reported to increase the gut membrane integrity. This chapter discusses the potential of metabiotics as an effective strategy for prophylaxis or therapeutic option in treatment of CRC.
dc.format.extent	16
dc.language	en
dc.publisher	Springer
dc.relation.ispartof	Probiotic Research in Therapeutics
dc.relation.isbasedon	10.1007/978-981-15-8214-1_5
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Metabiotics in Colorectal Cancer: Crosstalk Between Gut Microbiota and Host Pathology
dc.type	Chapter
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2023-01-06T23:04:17Z
pubs.place-of-publication	Singapore
pubs.publication-status	Published
dc.location	Singapore

Abstract:

After an extensive research and successful commercialization of probiotics in the past three decades, some scepticism regarding their safety and reproducibility of therapeutic advantage paved the way for “metabiotics”. The name metabiotics is a portmanteau created from the terms metabolites and probiotics. Also known as parabiotics and postbiotics, metabiotics are components of probiotic microorganisms and/or their metabolites with a determined chemical structure, which have been reported to be effective in the prevention and treatment of colorectal cancer (CRC). The main components of metabiotics are short-chain fatty acids (SCFAs), peptides, peptidoglycan-derived muropeptides, enzymes, polysaccharides, vitamins, teichoic acids, proteins and plasmalogens. Metabiotics help in the maintenance of GIT homeostasis and lead to proliferation of the healthy bacteria, which in turn reduces the levels of enzymes that are responsible for conversion of pro-carcinogens to carcinogens. Some components of metabiotics, specifically, SCFAs, have the ability to recognize cancer cells and de-repress the epigenetically silenced genes in them. The chemoprotective enzymes, secretory glycoproteins, certain exopolysaccharides and SCFAs all possess anti-mutagenic properties and exert a prophylactic effect against colorectal cancer. Apart from this, these components regulate the immune function and downregulate the inflammatory mediators, the most prominent causative factor in the development of CRC. Metabiotics have also demonstrated the anti-proliferative effects and have been reported to increase the gut membrane integrity. This chapter discusses the potential of metabiotics as an effective strategy for prophylaxis or therapeutic option in treatment of CRC.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/164764